HMGB1 and leukemia: It is suggested that HMGB1, as a DAMP molecule, is upregulated and released to adapt leukemia cells to chemotherapy, while RAGE, acting as HMGB1’s receptor, affects downstream signalling and promotes leukemia cell survival by regulations of autophagy, apoptosis as well as multidrug resistant proteins.